Press Esc to close
Saturday 01 November 2014
News updated at 3:58 PM IST
Weather
Max: 25°C
Min : 19°C
In Bangalore
Partially cloudy

Apex court verdict in Glivec case on Monday

Kalyan Ray, New Delhi, March 30, 2013 DHNS

After seven years of legal wranglings, the Supreme Court on Monday will deliver its verdict on the contentious patenting status of Glivec, an expensive anti-cancer drug, manufactured by pharmaceutical major Novartis.

After being denied protection on the molecule in India, Novartis challenged a key provision in the Indian Patent Act that inhibits protection of intellectual property rights on variants of an existing molecule unless there is significant therapeutic improvement.

The court verdict may also touch upon the price of leukaemia drug Glivec and other expensive drugs whose cheap generic versions are available in the market.


Glivec (imatinib mesylate) is the salt form of a previously known anti-cancer drug, sold in India for a price of Rs 1, 20,000 ($2,400) per patient per month. Indian firms sell its generic versions for Rs 8,000– 10,000 ($160–200) per patient per month. Since the original molecule was developed before 1995, it does not have a product patent in India.

Because of the World Trade Organisation requirement, India in 1995 agreed to allow patenting of pharmaceutical products and processes under Trade Related Aspects of Intellectual Property Rights (TRIPS) within 10 years.

While amending the patent law to meet this requirement in 2005, the government introduced Section 3(d) of the Indian Patent Act, prohibiting patents on variants of existing compounds that do not show enhanced efficacy. It was done ostensibly to take care of public health taking advantage of a TRIPS provision.

The pharmaceutical industry argues this clause establishes an unacceptably high barrier to patenting and limits incentive for research. But many others defend the law as a way to promote public health by enabling more drugs—particularly those who are hugely expensive—to be produced as generics.

Citing 3(d), Indian Patent Office in 2006 rejected Novartis’ application for a patent on the crystalline form of the basic compound in Glivec.

The company not only challenged the decision in Chennai High Court but also moved a separate petition questing the constitutional validity of the section 3(d). The High Court ruled against Novartis in 2007 and two years later Intellectual Property Appellate Board turned down Novartis plea on the patent cover for Glivec. Novartis moved the apex court in 2009.

The Supreme Court’s judgment could very well be a watershed verdict setting the ground rule on patent protection of many new medicines, which may only have an incremental benefit from its predecessor.

Go to Top

Photo Gallery
A view of the statue of Sardar Vallabhbhai Patel on the occasion of his birth anniversary...

A view of the statue of Sardar Vallabhbhai Patel on the occasion of his birth anniversary...

Congress President Sonia Gandhi and Rahul Gandhi paying tribute to former Prime Minister...

Congress President Sonia Gandhi and Rahul Gandhi paying tribute to former Prime Minister...

Artists perform during a function on the occasion of birth anniversary of Sardar...

Artists perform during a function on the occasion of birth anniversary of Sardar...

Members of Thamizhar Vazhvurimai Koottamaippu during a protest against Sri Lankan court's...

Members of Thamizhar Vazhvurimai Koottamaippu during a protest against Sri Lankan court's...

Indian cricket players during their practice session at barabati stadium in Cuttack...

Indian cricket players during their practice session at barabati stadium in Cuttack...

Delhi Police band performs at India Gate near Amar Jawan Jyoti to salute Sardar...

Delhi Police band performs at India Gate near Amar Jawan Jyoti to salute Sardar...

Army soldiers patrolling after an IED was recovered in a gas cylinder near the Circuit House...

Army soldiers patrolling after an IED was recovered in a gas cylinder near the Circuit House...

Tourist take pictures from a boat as people bath in the Ganges river in Varanasi...

Tourist take pictures from a boat as people bath in the Ganges river in Varanasi...

Devendra Fadnavis being sworn-in as the new Maharashtra Chief Minister by Governor...

Devendra Fadnavis being sworn-in as the new Maharashtra Chief Minister by Governor...

A camel herder sits as he feeds his camels at the annual cattle fair in Pushkar, in the Rajasthan...

A camel herder sits as he feeds his camels at the annual cattle fair in Pushkar, in the Rajasthan...

Copyright 2014, The Printers (Mysore) Private Ltd., 75, M.G Road, Post Box 5331, Bangalore - 560001
Tel: +91 (80) 25880000 Fax No. +91 (80) 25880523